Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus ; volume:14 ; number:4 ; day:21 ; month:3 ; year:2024 ; pages:919-932 ; date:4.2024
Dermatology and therapy ; 14, Heft 4 (21.3.2024), 919-932, 4.2024
- Urheber
-
Gargiulo, Luigi
Ibba, Luciano
Malagoli, Piergiorgio
Burroni, Anna G.
Chiricozzi, Andrea
Dapavo, Paolo
Ferrucci, Silvia M.
Gola, Massimo
Napolitano, Maddalena
Ortoncelli, Michela
Rossi, Maria T.
Sciarrone, Claudio
Costanzo, Antonio
Narcisi, Alessandra
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13555-024-01135-x
- URN
-
urn:nbn:de:101:1-2407092113362.101485514877
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gargiulo, Luigi
- Ibba, Luciano
- Malagoli, Piergiorgio
- Burroni, Anna G.
- Chiricozzi, Andrea
- Dapavo, Paolo
- Ferrucci, Silvia M.
- Gola, Massimo
- Napolitano, Maddalena
- Ortoncelli, Michela
- Rossi, Maria T.
- Sciarrone, Claudio
- Costanzo, Antonio
- Narcisi, Alessandra
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Atopic dermatitis
Atopic dermatitis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD
Skin microbiota of first cousins affected by psoriasis and atopic dermatitis
Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
Biomarkers in Atopic Dermatitis
Neutrophils in Atopic Dermatitis
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Atopic dermatitis
Atopic dermatitis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD
Skin microbiota of first cousins affected by psoriasis and atopic dermatitis
Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
Biomarkers in Atopic Dermatitis
Neutrophils in Atopic Dermatitis
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Atopic dermatitis
Atopic dermatitis
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD
Skin microbiota of first cousins affected by psoriasis and atopic dermatitis
Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
Lebrikizumab provides rapid response in EASI components and itch in moderate-to-severe atopic dermatitis
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
Biomarkers in Atopic Dermatitis